Abstract
Intra-atrial-reentrant-tachycardia (IART) is a common source of morbidity in adults with congenital heart disease (ACHD). Most patients (pts) that present with IART are treated with direct current cardioversion (DCCV). There is limited data on the efficacy of intravenous (IV) anti-arrhythmics for acute conversion of IART in the ACHD population.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have